Concepedia

Erika Martinelli

EM

78

Publications

6.9K

Citations

39

H-Index

2001

Active since

Affiliations

University of Campania "Luigi Vanvitelli"(Current)

University of Naples Federico II

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Casa Sollievo della Sofferenza

Istituti di Ricovero e Cura a Carattere Scientifico

Erika Martinelli is an author at University of Campania "Luigi Vanvitelli" specializing in oncology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2001–2025

78

Publications

78

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Arndt Vogel, Andrés Cervantes, Ian Chau et al. · Annals of Oncology · 2018 · 1K citations

, , +9

Dose- and Schedule-Dependent Inhibition of the Mammalian Target of Rapamycin Pathway With Everolimus: A Phase I Tumor Pharmacodynamic Study in Patients With Advanced Solid Tumors

Josep Tabernero, Federico Rojo, Emiliano Calvo et al. · Journal of Clinical Oncology · 2008 · 528 citations

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Arndt Vogel, Erika Martinelli, Arndt Vogel et al. · Annals of Oncology · 2021 · 436 citations

, , +11

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

Kei Muro, Florian Lordick, Takahiro Tsushima et al. · Annals of Oncology · 2018 · 284 citations

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 246 citations · Full text

, , +9

Rows per page

1–5 of 78